Plain-English translation of NCT07644832 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Hemophilia A research guide →Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This trial is testing a new medication called to see if it can safely help people with hemophilia A, hemophilia B, or Factor VII deficiency—conditions where the blood doesn't clot properly. Researchers will give participants either a single dose or multiple doses of the medication as an injection under the skin, and monitor how well it works and whether it causes any side effects.
People with these bleeding disorders currently rely on frequent treatments to prevent and manage bleeding episodes, which can significantly impact their quality of life. This trial aims to see whether this new treatment could be a safer, more effective, or more convenient option for managing these conditions.
You likely qualify if…
You likely don't qualify if…
Depending on which part of the trial you join, you will either receive a single injection or multiple injections under the skin over several weeks or months. You'll have regular blood tests and clinic visits to monitor how the medication works, check for side effects, and track your bleeding episodes. The trial will last several months, and you'll be asked to keep detailed records of any bleeding and treatments you receive.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
China